Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC).

Infusion-related reactions are common during or after the administration of liposomal drugs. For example, up to 10% of patients treated with Doxil® (pegylated liposomal doxorubicin) experience acut...